Literature DB >> 7016901

Selective medium for isolation of Clostridium botulinum from human feces.

M Dezfulian, L M McCroskey, C L Hatheway, V R Dowell.   

Abstract

A selective medium, Clostridium botulinum isolation (CBI) agar, was developed for the isolation of C. botulinum from human feces. This medium contains cycloserine (250 microgram/ml), sulfamethoxazole (76 microgram/ml), and trimethoprim (4 microgram/ml) as selective inhibitory agents. Qualitative tests indicated complete recovery of C. botulinum types A, B, F, and G on CBI medium. It was more difficult to recognize type G colonies on the medium because of their lack of lipase activity. Except for a few species of Clostridium, the growth of other obligate anaerobes and of the facultative anaerobes tested on CBI medium was suppressed. Quantitative studies of C. botulinum on the selective medium yielded counts comparable to those obtained on egg yolk agar control plates. Isolation of C. botulinum types A, B, and F from seeded fecal specimens was easily achieved with CBI medium. The use of CBI agar should aid the rapid isolation of C. botulinum from fecal specimens associated with foodborne and infant botulism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016901      PMCID: PMC273826          DOI: 10.1128/jcm.13.3.526-531.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Another type of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

3.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

4.  Selective and enhanced recovery of group A and B streptococci from throat cultures with sheep blood agar containing sulfamethoxazole and trimethoprim.

Authors:  B A Gunn; D K Ohashi; C A Gaydos; E S Holt
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

5.  Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism.

Authors:  B W Wilcke; T F Midura; S S Arnon
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

6.  Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism.

Authors:  V R Dowell; L M McCroskey; C L Hatheway; G L Lombard; J M Hughes; M H Merson
Journal:  JAMA       Date:  1977-10-24       Impact factor: 56.272

7.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

8.  Production of phenylacetic and hydroxyphenylacetic acids by clostridium botulinum type G.

Authors:  C W Moss; C L Hatheway; M A Lambert; L M McCroskey
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

9.  Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.

Authors:  S H Willey; J G Bartlett
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

10.  Infant botulism. Identification of Clostridium botulinum and its toxins in faeces.

Authors:  T F Midura; S S Arnon
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

View more
  31 in total

1.  Distribution of botulinum toxin-producing clostridia in soils of Argentina.

Authors:  Carolina Lúquez; María I Bianco; Laura I T de Jong; María D Sagua; Graciela N Arenas; Alberto S Ciccarelli; Rafael A Fernández
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

2.  An atypical outbreak of food-borne botulism due to Clostridium botulinum types B and E from ham.

Authors:  Christelle Mazuet; Jean Sautereau; Christine Legeay; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

3.  Transposon Tn916 mutagenesis in Clostridium botulinum.

Authors:  W J Lin; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1991-10       Impact factor: 4.792

4.  Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.

Authors:  D Akbulut; K A Grant; J McLauchlin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Kinetics of growth and toxigenicity of Clostridium botulinum in experimental wound botulism.

Authors:  M Dezfulian; J G Bartlett
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants.

Authors:  D C Mills; T F Midura; S S Arnon
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Selective and differential medium for detecting Clostridium botulinum.

Authors:  J C Silas; J A Carpenter; M K Hamdy; M A Harrison
Journal:  Appl Environ Microbiol       Date:  1985-10       Impact factor: 4.792

8.  Lyophilized airborne Clostridium botulinum spores as inocula that intestinally colonize antimicrobially pretreated adult mice.

Authors:  H Sugiyama; J L Prather; M J Woller
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

9.  Colony immunoblot assay of botulinal toxin.

Authors:  M C Goodnough; B Hammer; H Sugiyama; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1993-07       Impact factor: 4.792

10.  Rapid identification of Clostridium botulinum colonies by in vitro toxicity and antimicrobial susceptibility testing.

Authors:  M Dezfulian; J G Bartlett
Journal:  World J Microbiol Biotechnol       Date:  1994-01       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.